Howard Sandler
Cited by
Cited by
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix …
M Roach III, G Hanks, H Thames Jr, P Schellhammer, WU Shipley, ...
International Journal of Radiation Oncology* Biology* Physics 65 (4), 965-974, 2006
Quality of life and satisfaction with outcome among prostate-cancer survivors
MG Sanda, RL Dunn, J Michalski, HM Sandler, L Northouse, L Hembroff, ...
New England Journal of Medicine 358 (12), 1250-1261, 2008
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
JT Wei, RL Dunn, MS Litwin, HM Sandler, MG Sanda
Urology 56 (6), 899-905, 2000
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options
MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ...
The Journal of urology 199 (3), 683-690, 2018
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
AJ Stephenson, PT Scardino, MW Kattan, TM Pisansky, KM Slawin, ...
Journal of Clinical Oncology 25 (15), 2035-2041, 2007
Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the …
GE Hanks, TF Pajak, A Porter, D Grignon, H Brereton, V Venkatesan, ...
Journal of Clinical Oncology 21 (21), 3972-3978, 2003
Radiotherapy and short-term androgen deprivation for localized prostate cancer
CU Jones, D Hunt, DG McGowan, MB Amin, MP Chetner, DW Bruner, ...
New England Journal of Medicine 365 (2), 107-118, 2011
Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer
EM Horwitz, K Bae, GE Hanks, A Porter, DJ Grignon, HD Brereton, ...
Journal of Clinical Oncology 26 (15), 2497-2504, 2008
Radiation with or without antiandrogen therapy in recurrent prostate cancer
WU Shipley, W Seiferheld, HR Lukka, PP Major, NM Heney, DJ Grignon, ...
New England Journal of Medicine 376 (5), 417-428, 2017
Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer
WR Lee, JJ Dignam, MB Amin, DW Bruner, D Low, GP Swanson, ...
Journal of Clinical Oncology 34 (20), 2325-2332, 2016
Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy
JL Chan, SW Lee, BA Fraass, DP Normolle, HS Greenberg, LR Junck, ...
Journal of clinical oncology 20 (6), 1635-1642, 2002
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
HA Gay, HJ Barthold, E O’Meara, WR Bosch, I El Naqa, R Al-Lozi, ...
International Journal of Radiation Oncology* Biology* Physics 83 (3), e353-e362, 2012
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer
JT Wei, RL Dunn, HM Sandler, PW McLaughlin, JE Montie, MS Litwin, ...
Journal of Clinical Oncology 20 (2), 557-566, 2002
Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis
WU Shipley, HD Thames, HM Sandler, GE Hanks, AL Zietman, CA Perez, ...
Jama 281 (17), 1598-1604, 1999
Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer
TR Willoughby, PA Kupelian, J Pouliot, K Shinohara, M Aubin, M Roach III, ...
International Journal of Radiation Oncology* Biology* Physics 65 (2), 528-534, 2006
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy
DC Miller, MG Sanda, RL Dunn, JE Montie, H Pimentel, HM Sandler, ...
Journal of Clinical Oncology 23 (12), 2772-2780, 2005
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management
CK Bichakjian, L Lowe, CD Lao, HM Sandler, CR Bradford, TM Johnson, ...
Cancer 110 (1), 1-12, 2007
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer
JM Michalski, C Lawton, I El Naqa, M Ritter, E O'Meara, MJ Seider, ...
International Journal of Radiation Oncology* Biology* Physics 76 (2), 361-368, 2010
Measurement of prostate movement over the course of routine radiotherapy using implanted markers
JM Balter, HM Sandler, K Lam, RL Bree, AS Lichter, RK Ten Haken
International Journal of Radiation Oncology* Biology* Physics 31 (1), 113-118, 1995
Prostate cancer–major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
MK Buyyounouski, PL Choyke, JK McKenney, O Sartor, HM Sandler, ...
CA: a cancer journal for clinicians 67 (3), 245-253, 2017
The system can't perform the operation now. Try again later.
Articles 1–20